Loading...
OrthoPediatrics Corp.
KIDS•NASDAQ
Healthcare
Medical - Devices
$20.72
$-0.96(-4.43%)
OrthoPediatrics Corp. (KIDS) Financial Performance & Income Statement Overview
Review OrthoPediatrics Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
37.65%
↑ 37.65%
Operating Income Growth
-14.57%
↓ 14.57%
Net Income Growth
-80.33%
↓ 80.33%
Operating Cash Flow Growth
-0.01%
↓ 0.007%
Operating Margin
-14.47%
↓ 14.47%
Gross Margin
70.56%
↑ 70.56%
Net Profit Margin
-19.15%
↓ 19.15%
ROE
-11.27%
↓ 11.27%
ROIC
-7.10%
↓ 7.10%
OrthoPediatrics Corp. (KIDS) Income Statement & Financial Overview
Review OrthoPediatrics Corp.'s (KIDS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $52.67M | $54.57M | $52.80M | $44.69M |
| Cost of Revenue | $17.10M | $14.51M | $16.78M | $17.54M |
| Gross Profit | $35.56M | $40.06M | $36.02M | $27.15M |
| Gross Profit Ratio | $0.68 | $0.73 | $0.68 | $0.61 |
| R&D Expenses | $2.92M | $2.58M | $2.54M | $3.00M |
| SG&A Expenses | $41.22M | $43.05M | $39.14M | $33.87M |
| Operating Expenses | $49.62M | $45.63M | $41.69M | $36.87M |
| Total Costs & Expenses | $61.23M | $60.14M | $58.47M | $54.41M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.32M | $404000.00 | $261000.00 | $637000.00 |
| Depreciation & Amortization | $3.99M | $5.28M | $4.78M | $5.03M |
| EBITDA | -$11.10M | -$3.45M | -$1.007M | -$4.70M |
| EBITDA Ratio | -$0.21 | -$0.06 | -$0.02 | -$0.11 |
| Operating Income | -$8.57M | -$5.57M | -$5.67M | -$9.72M |
| Operating Income Ratio | -$0.16 | -$0.10 | -$0.11 | -$0.22 |
| Other Income/Expenses (Net) | -$7.84M | -$3.57M | -$381000.00 | -$613000.00 |
| Income Before Tax | -$16.41M | -$9.14M | -$6.05M | -$10.34M |
| Income Before Tax Ratio | -$0.31 | -$0.17 | -$0.11 | -$0.23 |
| Income Tax Expense | -$340000.00 | -$1.22M | -$18000.00 | -$2.53M |
| Net Income | -$16.07M | -$7.92M | -$6.03M | -$7.80M |
| Net Income Ratio | -$0.31 | -$0.15 | -$0.11 | -$0.17 |
| EPS | -$0.70 | -$0.34 | -$0.26 | -$0.34 |
| Diluted EPS | -$0.70 | -$0.34 | -$0.26 | -$0.34 |
| Weighted Avg Shares Outstanding | $23.17M | $23.17M | $23.15M | $22.82M |
| Weighted Avg Shares Outstanding (Diluted) | $23.17M | $23.17M | $23.15M | $22.82M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan